← Leaderboards
Noah Weisleder
Univ Of Med/Dent Nj-R W Johnson Med Sch
$7,316,258
Attributed
$9,858,814
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,858,814 · 11
By mechanism
R01$6,196,405 · 4
R42$1,694,079 · 1
R00$730,125 · 1
R56$594,445 · 2
R41$484,298 · 2
K99$159,462 · 1
Top collaborators
- Marco Brotto6 shared
- Wael N Jarjour3 shared
- Robert J Bloch2 shared
Others in their field
Top investigators on “Muscle”
- Kenton M Sanders · University Of Nevada Reno$54,512,961
- Lynn A Sleeper · New England Research Institutes, Inc.$48,671,277
- Clifford B Saper · Harvard University (Medical School)$38,171,545
- Charles P Emerson · University Of Pennsylvania$37,572,397
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$36,830,932
- Mary McGrae McDermott · Northwestern University$36,469,369
Research focus
MuscleMembraneLinkMouse ModelProteinsMyopathyMuscle CellsPathologyGenesMuscle FibersMuscle FunctionSignal TransductionIn VivoSkeletal MuscleMedicalMuscular DystrophiesOverexpressionCellsInjuryMutationPhenotypeMolecularGenerationsRepaired
Grant awards (26)
Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy$587,105
R42 · FY2025 · AR · contact PI
C2 domain therapeutics for muscular dystrophy$518,611
R01 · FY2025 · AR
Autoantibodies to membrane repair proteins in myositis$403,624
R01 · FY2025 · AR
Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy$811,438
R42 · FY2024 · AR · contact PI
C2 domain therapeutics for muscular dystrophy$541,661
R01 · FY2024 · AR
Autoantibodies to membrane repair proteins in myositis$463,039
R01 · FY2024 · AR
Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy$295,536
R42 · FY2023 · AR · contact PI
Regulation of Store-Operated Calcium Entry During Muscle Aging$494,339
R01 · FY2022 · AG · contact PI
Cell Membrane Resealing in Inflammatory Myopathy$284,217
R56 · FY2022 · AR
Translational development of recombinant protein therapeutic for LGMD2B$259,487
R41 · FY2022 · AR · contact PI
Regulation of Store-Operated Calcium Entry During Muscle Aging$502,318
R01 · FY2021 · AG · contact PI
Regulation of Store-Operated Calcium Entry During Muscle Aging$510,119
R01 · FY2020 · AG · contact PI
Regulation of Store-Operated Calcium Entry During Muscle Aging$517,747
R01 · FY2019 · AG · contact PI
Optimizing membrane repair for the treatment of Duchenne muscular dystrophy$224,811
R41 · FY2019 · AR · contact PI
Regulation of Store-Operated Calcium Entry During Muscle Aging$539,210
R01 · FY2018 · AG · contact PI
Targeting Membrane Repair in Muscular Dystrophy$346,500
R01 · FY2016 · AR · contact PI
Targeting Membrane Repair in Muscular Dystrophy$346,500
R01 · FY2015 · AR · contact PI
MG29 function in regulation of Store-Operated Calcium Entry during Muscle Aging$310,228
R56 · FY2015 · AG · contact PI
Targeting Membrane Repair in Muscular Dystrophy$339,570
R01 · FY2014 · AR · contact PI
Targeting Membrane Repair in Muscular Dystrophy$328,729
R01 · FY2013 · AR · contact PI
Calcium Regulation in the Progression of Muscular Dystrophy$232,127
R00 · FY2013 · AR · contact PI
Targeting Membrane Repair in Muscular Dystrophy$344,438
R01 · FY2012 · AR · contact PI
Calcium Regulation in the Progression of Muscular Dystrophy$248,999
R00 · FY2012 · AR · contact PI
Calcium Regulation in the Progression of Muscular Dystrophy$248,999
R00 · FY2011 · AR · contact PI
Calcium Regulation in the Progression of Muscular Dystrophy$79,731
K99 · FY2009 · AR · contact PI
Calcium Regulation in the Progression of Muscular Dystrophy$79,731
K99 · FY2008 · AR · contact PI